Market Size of Pipette Controllers Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 4.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Pipette Controllers Market Analysis
The pipette controllers market is anticipated to register a CAGR of 4.5% over the forecast period.
- Research in numerous scientific fields experienced slowdowns due to the COVID-19 pandemic, except for COVID-19-related studies. Yet, significant advancements in COVID-19 detection emerged, particularly using diverse lab equipment, profoundly influencing the market amid the pandemic. As of March 2021, a report by Integra Biosciences highlighted that their Voyager adjustable tip spacing pipette played a pivotal role in aiding research teams to swiftly develop COVID-19 testing kits. These electrical pipettes with better consistency reduce the time for sampling and are likely to increase usage, which is expected to have a significant impact on the market during the pandemic period. The demand for the post-pandemic period is unpredictable due to the decreased cases of COVID-19 and decreased research activities on COVID-19 detection kits.
- Certain factors that are driving the market growth include increasing R&D activities and the advantages associated with electric pipette controllers. The healthcare industry is observing a huge rise in R&D activities to address several challenges associated with the rising prevalence of various diseases. Globally, the disease burden is shifting from infectious diseases to chronic conditions, with a corresponding escalation in the burden of cancer.
- Furthermore, the increasing research and development funding likely increases research activities and is expected to propel the market to grow. For instance, as per the European Federation of Pharmaceutical Industries and Associations (EFPIA) report 2022, the pharmaceutical R&D expenditure in Europe is estimated to be EUR 41,500 million (USD 49.07 billion) in 2021, which was compared to EUR 39,656 million (USD 46.84 billion) in the previous year. This shows the increasing R&D expenditure, which is expected to increase the research activities in the pharmaceutical industry and is likely to propel the market over the study period.
- In addition, the adoption of various pipette controllers in research activities is expected to boost the market. For instance, the report published by Rapid Test Methods Ltd in June 2022 stated that the University of Bayreuth's biophysics research group has been using Integra's Pipetboy acu 2, one of the most widely used pipette controllers, to prepare buffers, media, and samples for its cell culture workflows, streamlining culture set-up, splitting, and media exchange. This adoption of pipette controllers in research studies increases the usage and is expected to have significant growth in the market over the forecast period.
- However, the lack of skilled personnel is a major hindering factor for the growth of the market over the forecast period.
